First MyWAVE Training School (co-organised with EBEA)

Published on 27/10/2020

COST Action MyWAVE co-organised the 9th International School of Bioelectromagnetism “Alessandro Chiabrera” with the European BioElectromagnetics Association (EBEA).

“Possible Biomedical Applications of Electromagnetic Fields to cancer: from biology and in silico to clinical perspectives”

This training school was co-organised with the following goals:

The topics discussed during this training school were the following:

  • PHYSICAL PRINCIPLES OF EMF – EMF spectrum and general properties – Ferdinando Bersani, ELF generation and dosimetry – Stefania Romeo (Italy), RF generation and dosimetry – Rita Massa (Italy), Thermal and non-thermal effects of ELF and RF – Stefania Romeo (Italy)
  • BIOLOGICAL EFFECTS OF EMF IN RELATION TO CANCER – Introduction to biology of cancer  – Maja Cemazar (Slovenia).
  • Biological effects in vitro & in vivo – Static and ELF fields – Mats Olof Mattsson (Sweden), High frequency EMF – Maria Rosaria Scarfì (Italy), Static and ELF fields – Isabelle Lagroye (France), High frequency EMF – Isabelle Lagroye (France), What is learnt from epidemiology- Anke Huss (the Netherlands).
  • Dielectric properties of healthy and cancerous tissues – Charles V. Sammut (Malta)
  • Methodological problems in Bioelectromagnetics – General criteria for a good experimental practice in Bioelectromagnetics – biology– Maria Rosaria Scarfì (Italy) & Rita Massa (Italy)
  • EMFs IN DIAGNOSIS – Microwave imaging and its application in cancer diagnosis – Emily Porter (Ireland), Imaging with Terahertz and MMW – Mostafa Shalaby (Switzerland)
  • Seminar on COST Action “MyWave” Emily Porter (Ireland).

THERAPEUTIC APPLICATIONS: RESULTS AND PERSPECTIVES

  • Thermal effects: therapeutic perspectives – Hyperthermia – Gerard van Rhoon (The Netherlands), Thermal ablation – Luigi Solbiati (Italy).
  • Electroporation and electrochemotherapy – Preclinical and clinical aspects of electrochemotherapy – Gregor Sersa (Slovenia), Immunological principles of combined treatment with electrochemotherapy –  Emanuela Signori (Italy), New clinical developments in electrochemotherapy – July Gehl (Denmark).
  • Modeling and treatment planning for therapies of cancer – Hyperthermia – Theodoros Samaras (Greece), Ablative techniques – Theodoros Samaras (Greece), Modelling and treatment planning for Electrochemotherapy – Bor Kos (Slovenia).
  • RECENT PERSPECTIVES OF PMF IN RELATION TO CANCER THERAPY – PEMF and cancer cells: in vitro effects – Ruggero Cadossi (Italy), The long road to validate PEMF use in cancer patients – Ruggero Cadossi (Italy).
  • Devices on the market: a critical overview – Ferdinando Bersani (Italy).